Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Men can experience female pattern hair loss, needing different treatments.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

More research is needed to find the best long-term treatments for Alopecia Areata.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Erlotinib can cause hair loss as a side effect.

Testosterone helps human pancreatic cells increase insulin release.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Short-term finasteride use likely doesn't harm male fertility.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.